Archives
New 2020 AHA Guidelines for CPR and emergency cardiovascular care in adults and children
22 Oct, 2020 | 09:47h | UTCHighlights: 2020 AHA Guidelines Update for CPR and ECC
Executive Summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care
New calculator predicts risk of hospital admission and mortality from coronavirus 19 in adults
22 Oct, 2020 | 09:37h | UTCSee calculator: QCovid® risk calculator
Commentary on Twitter
A new "living" high quality prediction model for #COVID19 risk for hospitalization and mortality: top 20% risk accounted for 94% of deaths; https://t.co/aPXRM2pHCq calculatorhttps://t.co/gdd8b3j33K @bmj_latest
by @AshClift @JuliaHCox @OxPrimaryCare and colleagues pic.twitter.com/s8TrWWECb0— Eric Topol (@EricTopol) October 21, 2020
SARS-CoV-2 immunity: Review and applications to phase 3 vaccine candidates
22 Oct, 2020 | 09:36h | UTCSARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates – The Lancet
Commentary: The COVID-19 vaccine pipeline – News Medical
Commentary on Twitter
NEW Review—G Poland, I Ovsyannikova & R Kennedy @MayoClinic discuss what is currently known about human humoral & cellular immune responses to SARS-CoV-2 & relate this knowledge to the #COVID19 vaccines currently in phase 3 clinical trials https://t.co/eDkFq4WStA pic.twitter.com/hfw6yjviym
— The Lancet (@TheLancet) October 14, 2020
Will Covid-19 vaccines save lives? Current trials aren’t designed to tell us
22 Oct, 2020 | 09:40h | UTCWill covid-19 vaccines save lives? Current trials aren’t designed to tell us – The BMJ
Commentaries: COVID-19 vaccine trials won’t tell us if the shots save lives, expert notes – CNN AND Coronavirus vaccine trials won’t tell us if they save lives, prevent serious illness or stop transmission – here’s why – The Conversation
Commentary on Twitter
The world is waiting on a vaccine for covid-19 that will reduce the likelihood of getting severely ill and prevent infection. Yet the current phase III trials are not actually set up to prove either, finds Peter Doshi https://t.co/BSb9WiUQXo
— The BMJ (@bmj_latest) October 21, 2020
Meta-analysis: Efficacy and safety of tranexamic acid in acute traumatic brain injury
22 Oct, 2020 | 09:31h | UTC
Commentary on Twitter
Tranexamic acid in acute TBI
➡️ 9 RCTs/14,747 pts
➡️ probably NO effect on mortality or disability
➡️ may decrease hematoma expansion on subsequent imaging (likely of minor importance to pts)
➡️ probably NO increased risk of adverse events#FOAMcc @yourICM https://t.co/sqn80NfNv4 pic.twitter.com/dMf8rYowC2— Intensive Care Medicine (@yourICM) October 21, 2020
Study: COVID-19 mitigation measures linked to lower incidence of preterm birth
22 Oct, 2020 | 09:35h | UTCCommentary: Did Lockdowns Lower Premature Births? A New Study Adds Evidence – The New York Times
Meta-analysis: Dual antiplatelet therapy after percutaneous coronary intervention and drug-eluting stents
22 Oct, 2020 | 09:29h | UTC
Perspective: Immunity and Re-Infection
22 Oct, 2020 | 09:34h | UTCImmunity and Re-Infection – Science Translational Medicine
Imaging features and differential diagnoses of non-neoplastic diffuse mediastinal diseases
22 Oct, 2020 | 09:26h | UTC
Professionalism revealed: Rethinking quality improvement in the wake of a pandemic
22 Oct, 2020 | 09:32h | UTCProfessionalism Revealed: Rethinking Quality Improvement in the Wake of a Pandemic – NEJM Catalyst
ATS Conference coverage: Many patients prescribed home oxygen after an acute COPD exacerbation no longer meet the criteria two to three months later
22 Oct, 2020 | 09:25h | UTCBreathing easier from hospital to home – ACP Internist
Video consultations in primary and specialist care during the covid-19 pandemic and beyond
21 Oct, 2020 | 09:30h | UTCVideo consultations in primary and specialist care during the covid-19 pandemic and beyond – The BMJ
Studies offer little hope for Tocilizumab in treating COVID
21 Oct, 2020 | 09:27h | UTCStudies offer little hope for tocilizumab in treating COVID – CIDRAP
See studies: Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19 – JAMA Internal Medicine AND Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial – JAMA Internal Medicine AND Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial – JAMA Internal Medicine
Commentary: expert reaction to three studies of Tocilizumab to treat COVID patients – Science Media Centre
Related study (preprint): Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia – medRxiv
Meta-analysis: Evaluating prophylactic heparin in ambulatory patients with solid tumors
22 Oct, 2020 | 09:23h | UTCEvaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis – The Lancet Haematology (free registration required)
Dozens to be deliberately infected with coronavirus in UK ‘human challenge’ trials
21 Oct, 2020 | 09:25h | UTCDozens to be deliberately infected with coronavirus in UK ‘human challenge’ trials – Nature
Commentaries: U.K. Preparing COVID-19 Vaccine Trials That Deliberately Expose Study Subjects – NPR AND UK plan to be first to run human challenge Covid trials – BBC
Viewpoint – COVID-19, children and non-communicable diseases: Translating evidence into action
21 Oct, 2020 | 09:19h | UTC
Commentary on Twitter
"The recognition that NCDs are a massive contributor to COVID-19 mortality and severe illness across all age groups should be a wake-up call to accelerate preventive strategies for NCDs."
New piece on how children & youth are affected by #COVID19 & #NCDshttps://t.co/oXV6UAdgGL pic.twitter.com/WNTZtVAztZ
— Marie Hauerslev (@HauerslevMarie) October 17, 2020
Studies point to big drop in COVID-19 death rates
21 Oct, 2020 | 09:23h | UTCStudies Point To Big Drop In COVID-19 Death Rates – NPR
‘Super antigens’ tied to mysterious COVID-19 syndrome in children
21 Oct, 2020 | 09:21h | UTC‘Super antigens’ tied to mysterious COVID-19 syndrome in children – National Geographic
Perspective: COVID-19 in children and young people
21 Oct, 2020 | 09:17h | UTCCOVID-19 in children and young people – Science
Guidelines for care of adults with Down Syndrome
21 Oct, 2020 | 09:14h | UTCMedical Care of Adults With Down Syndrome: A Clinical Guideline – JAMA (free for a limited period)
Editorial: Guidelines for Care of Adults With Down Syndrome
Updated Guideline: Coronavirus (COVID-19) infection in pregnancy
21 Oct, 2020 | 09:16h | UTCCoronavirus (COVID-19) Infection in Pregnancy – Royal College of Obstetricians & Gynaecologists
COVID-19 and first trimester spontaneous abortion: a case-control study of 225 pregnant patients
21 Oct, 2020 | 09:15h | UTC
Meta-analysis: Drugs for preventing postoperative nausea and vomiting in adults after general anesthesia
21 Oct, 2020 | 09:13h | UTC
Commentary on Twitter
Very pleased to share our new #NMA on drugs for preventing #postoperative #nausea and #vomiting after general #anaesthesia: https://t.co/vwha2Vd3DL A huge effort (585 studies!), that involved assessing and ranking the effects of 28 drugs and 36 drug combinations from 6 classes.
— Cochrane Anaesthesia & Emergency and Critical Care (@Cochrane_ACE) October 20, 2020
Nature journals announce first open-access agreement
21 Oct, 2020 | 09:11h | UTCNature journals announce first open-access agreement – Nature
Clinical Report: Evaluation and management of the infant exposed to HIV in the US
21 Oct, 2020 | 09:09h | UTCEvaluation and Management of the Infant Exposed to HIV in the United States – Pediatrics
Commentaries: Pediatrics Group Updates Guidelines on Managing HIV-Exposed Infants – NEJM Journal Watch AND Perinatal Exposure to HIV Requires Specialized, Coordinated Care – AJMC